Clinical Trials
37
Active:37
Completed:0
Trial Phases
1 Phases
Phase 1:20
Drug Approvals
14
NMPA:14
Drug Approvals
Fludarabine Phosphate for Injection
- Product Name
- 福达华
- Approval Number
- 国药准字HJ20140464
- Approval Date
- Jul 13, 2023
NMPA
Fludarabine Phosphate for Injection
- Product Name
- 福达华
- Approval Number
- 国药准字HJ20140465
- Approval Date
- Jul 13, 2023
NMPA
Rabbit Anti-human Thymocyte Immunoglobulin
- Product Name
- 即复宁
- Approval Number
- 国药准字J20150136
- Approval Date
- Jun 3, 2020
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
Distribution across different clinical trial phases (20 trials with phase data)• Click on a phase to view related trials
Phase 1
20 (100.0%)No trials found
News
No news found